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Abstract; 
Objective; To determine the frequency of catheter induced thrombosis in patients with end stage renal disease 
(ESRD) on hemodialysis. Material and Methods; All the cases (86) undergoing hemodialysis were recruited 
from Department of Medicine, Nishtar Hospital Multan, Pakistan. Double lumen hemodialysis catheter was 
inserted by a senior consultant. Color Doppler sonography was done at the 6th day of placement of catheter and 
presence of thrombus was noted in the study proforma. History was taken for hypertension, smoking, family 
history and previous history of thrombosis. Results; Of these 86 study cases, 51 (59.3 %) were male patients and 
35 (40.7%) were female patients. Mean age of our study cases was 45.62 ± 8.44 years. Of these 86 patients 28 
(32.6%) were diabetic, 35 (40.7%) were hypertensive, 34 (39.5%) were smokers and 07 (8.1%) had previous 
history of thrombosis. Mean duration of catheter placement was 81.62 ± 41.67 days and mean duration on 
hemodialysis was 22.36 ± 10.43 months. Majority of our study cases i.e. 65 (75.6%) had to undergo 
hemodialysis three times in one week. Catheter related thrombosis was noted in 29 (33.7%) of our study cases. 
Conclusion; Frequency of catheter-related thrombosis was high in patients with end-stage renal disease (ESRD) 
in our study. Thrombosis in ESRD patients was significantly associated with male gender, age, duration of 
catheter placement and duration of hemodialysis. 
Keywords; End-stage renal disease, catheter, thrombosis.  
 
Introduction; 
Central venous catheters (CVCs) refer to vascular access devices indicated for the administration of intravenous 
medication treatments, fluids, or total parenteral nutrition, repeated blood sampling, and for hemodialysis (HD)
1-
4. Use of CVCs for HD has increased in recent years, comprising approximately 25% of prevalent HD patients in 
the United States; this is despite the recommendation by the National Kidney Foundation that tunneled, cuffed 
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catheters for HD access be limited to <10% of prevalent dialysis patients due to the greater risk of morbidity and 
mortality
4
. 
However, several complications resulting from the use of CVCs, including sepsis, extravasation of infusions, 
and venous thrombosis, can increase associated morbidity and mortality. These complications can also interrupt 
and delay treatment for the underlying disease and thereby affect outcome. The most common CVC 
complications are occlusion and catheter-related thrombosis (CRT)
 5
. Patients with CVCs are prone to CRT 
because of the direct effects of the catheter on the adjacent veins and blood flow, underlying disease and its 
treatment, nature of substances being infused, and location and time of placement of the catheter. A CRT occurs 
most often in the upper extremity where most long-term catheters are located.
 
Symptoms include pain, 
tenderness to palpation, swelling, edema, warmth, erythema, and development of collateral vessels in the 
surrounding area. Risk factors for CRT include previous catheter infections, malposition of the catheter tip, and 
prothrombotic states. CRT can lead to catheter infection, pulmonary embolism, and post-thrombotic syndrome6-
10
. CRT is diagnosed primarily using Doppler ultrasound or venography and treated with anticoagulation for 6 
weeks to a year, depending on the extent of the thrombus, response to initial therapy, and whether thrombophilic 
factors persist. Prevention of CRT includes proper positioning of the CVC and prevention of infections; 
anticoagulation prophylaxis is not recommended at present.
11 
Kujur et al 
12 
from India reported 33% frequency of 
catheter related thrombosis in a prospective study conducted in such patients.  
 
Material and Methods; 
All the cases (86) undergoing hemodialysis were recruited from Department of Medicine, Nishtar Hospital 
Multan, Pakistan. Known patients of CAD and Coagulopathy on lab report, diagnosed cases of malignancy and 
tuberculous meningitis, bed ridden patients such as post surgical patients and with CVA were excluded from our 
study. Detailed history and physical examination was done for these study cases. All the relevant baseline 
investigations were arranged. For this purpose, Venous blood (3 ml) sample was drawn and sent to the central 
laboratory of Nishtar Hospital Multan for the blood glucose level estimation (FBS) and CBC. Double lumen 
hemodialysis catheter was inserted by a senior consultant. Color Doppler sonography was done at the 6
th
 day of 
placement of catheter and presence of thrombus was noted in the study proforma. History was taken for 
hypertension, smoking, family history and previous history of thrombosis.  
 
Results; 
Our study included a total of 86 study cases who met inclusion and exclusion criteria of our study. Of these 86 
study cases, 51 (59.3 %) were male patients and 35 (40.7%) were female patients. Mean age of our study cases 
was 45.62 ± 8.44 years (with minimum age was 32 years while maximum age was 58 years). Mean age of the 
male patients was 42.75 ± 8.76 years while that of female patients was 49.80 ± 5.63 years (p= 0.000). our study 
results have concluded that majority of our study cases i.e. 56 (65.1%) were aged more than 40 years. Of these 
86 patients 28 (32.6%) were diabetic, 35 (40.7%) were hypertensive, 34 (39.5%) were smokers and 07 (8.1%) 
had previous history of thrombosis. Mean duration of catheter placement was 81.62 ± 41.67 days (with minimum 
duration of placement was 18 days while maximum duration was 210 days) and majority of our study cases i.e. 
58 (67.4%) had catheter placement for less than 90 days. Mean duration on hemodialysis was 22.36 ± 10.43 
months (with minimum duration on hemodialysis was 3 months while maximum was 36 months) and most of 
our patients (58.3%) were on hemodialysis for more than 18 months. Majority of our study cases i.e. 65 (75.6%) 
had to undergo hemodialysis three times in one week. Catheter related thrombosis was noted in 29 (33.7%) of 
our study cases. 
 
Discussion; 
Catheter-related thrombosis (CRT) is a relatively common complication in patients with long-term indwelling 
CVCs and may pose clinicians with difficult decisions on what anticoagulant treatment to choose and whether 
the CVC must be removed 13.  
Our study included a total of 86 patients with end stage renal disease (ESRD) on hemodialysis meeting 
inclusion and exclusion criteria of this study. Different studies have reported end stage renal disease to be more 
prevalent in male patients, similarly Of these 86 study cases, 51 (59.3 %) were male patients and 35 (40.7%) 
were female patients. A Chinese study conducted by Wang et al 
14
 reported 57 % male gender predominance 
which is close to our study results. Menon et al 
15
 also reported male patients predominating over female patients 
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(58 % versus 42 %) which is same as that of our study results. A study conducted by Iftikhar et al 
16
 from Lahore 
has reported 58 % male patients with ESRD and 42 % female patients, these findings are same as that of our 
study results. Siddiqui et al from Rawalpindi 17 reported 67 % male patients with ESRD which is in compliance 
with that of our study results. Another study conducted by gazzaza et al from Saudi Arabia 
18
 also reported male 
patients predominance in 61 % ESRD patients and female patients were only 39 %, which is similar to that of 
our study results. Machingura et al 
19
 from Zimbabwe has reported male gender predominance in 70 % patients 
with ESRD on hemodialysis, these findings are close to that of our study results.  
Mean age of our study cases was 45.62 ± 8.44 years (with minimum age was 32 years while maximum age was 
58 years). Mean age of the male patients was 42.75 ± 8.76 years while that of female patients was 49.80 ± 5.63 
years (p= 0.000). Our study results have concluded that majority of our study cases i.e. 56 (65.1%) were aged 
more than 40 years and similar findings have been reported by Wang et al 104 from China. Machingura et al 19 
reported 46.7 ± 13.5 years mean age of these patients of ESRD on hemodialysis, these findings are close to that 
of our study results. A study conducted in Lahore by Anees et al 
120
 has reported 46.10 ± 16.29 years mean age 
of patients with ESRD on hemodilaysis, these findings are similar to that of our study results. Another study by 
Siddiqui et al 17 has reported 44.5 ±  14.3 years mean age of ESRD patients on hemodialysis which are in 
consistence with our study findings.  
Of these 86 patients 28 (32.6%) were diabetic, 35 (40.7%) were hypertensive, 34 (39.5%) were smokers and 07 
(8.1%) had previous history of thrombosis. A study by Wang et al 
14
 from China reported 27 % diabetes which is 
close to our study results, however they reported hypertension only in 11% patients which is quite low than our 
findings. Anees et al 120 reported similar findings.   
Mean duration on hemodialysis was 22.36 ± 10.43 months (with minimum duration on hemodialysis 
was 3 months while maximum was 36 months) and most of our patients (58.3%) were on hemodialysis for more 
than 18 months. Majority of our study cases i.e. 65 (75.6%) had to undergo hemodialysis three times in one 
week.  Anees et al 
120
 reported mean duration on hemodialysis to be 24.87 ± 22.1 months which is similar to that 
of our findings. Wang et al 
14
 from China reported 26.5 months mean duration of hemodialysis which is 
consistent to our study results.  
Mean duration of catheter placement was 81.62 ± 41.67 days (with minimum duration of placement was 18 days 
while maximum duration was 210 days) and majority of our study cases i.e. 58 (67.4 %) had catheter placement 
for less than 90 days. Similar findings have been reported by Wang et al 
14
.  
Catheter related thrombosis was noted in 29 (33.7%) of our study cases. Kujur et al 
12 
from India reported 33% 
frequency of catheter related thrombosis in a prospective study conducted in such patients. These results are 
similar to our study results.  
 
Conclusion; 
Frequency of catheter-related thrombosis was high in patients with end-stage renal disease (ESRD) in our study. 
Thrombosis in ESRD patients was significantly associated with male gender, age, duration of catheter placement 
and duration of hemodialysis. Anticipation, early diagnosis and early management of thrombosis can play a key 
role to decrease disease morbidity and mortality. This will also improve quality of life of these patients and will 
also save their increased medical costs.  
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